
Billion-dollar Hong Kong IPOs keep coming as China’s biggest drug company joins rush
Initial public offering (IPO) plans keep rolling in for Hong Kong’s revitalised capital market, with China’s largest pharmaceutical company launching another billion-dollar deal on Thursday. Shanghai-listed Jiangsu Hengrui Pharmaceuticals aims to raise as …